Bachem continues to grow and increases dividend
Group sales rise to CHF 577.3 million (+8.6%) in 2023. EBITDA at CHF 166.7 million (+3.9%) with a margin of 28.9%. Stro…
Group sales rise to CHF 577.3 million (+8.6%) in 2023. EBITDA at CHF 166.7 million (+3.9%) with a margin of 28.9%. Stro…
ProteinQure, the leading startup in the computational design of peptide drugs, announces a significant breakthrough in t…
PENTIXAPHARM GmbH, a 100% subsidiary of Eckert & Ziegler AG (ISIN DE0005659700, SDAX), received green light from the Eur…
Helps to repair damaged hair, and to protect it from daily aggressions Upcycled plant extract from Silybum marianum seed…
INAM - The Innovation Network for Advanced Materials is proud to announce the selection of eleven remarkable startups fo…
Collaboration combines leading technologies to develop breakthrough, mRNA-enabled in vivo expressed TCER® molecules Comp…
VelaLabs announces that it has successfully been granted the extension of its GLP certification for another 3 years. A…
- An exclusive supply agreement with Caregen enables BASF to expand its dermocosmetics portfolio - Peptovitae™ series ad…
Lonza meets pressing market need by launching first ever coating-free capsule to support intestinal delivery of acid-sen…
Allergens and alimentary intolerances are a worldwide food safety issue with an increasing prevalence and number of alle…